Results 291 to 300 of about 22,320,192 (343)

ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction

Ultrasound in Obstetrics &Gynecology, EarlyView.
T.  Stampalija, C.  Lees, T.  Ghi, J.  Cornette, W.  Gyselaers, E.  Ferrazzi, T.  Mousa, M.  Spaanderman, B.  Thilaganathan, H.  Valensise, Collaborators, J. J. Duvekot, C. Ghossein‐Doha, C. McEniery, F. Mecacci, G. P. Novelli, B. Vasopollo, I. Wilkinson   +17 more
wiley   +1 more source

Sclerosing diseases of the skin

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Yasamin Kalantari, Katharina Meier, Kamran Ghoreschi, Maria Kinberger, Farzan Solimani   +4 more
wiley   +1 more source

Status quo and future developments in the diagnosis and treatment of hereditary angioedema

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Hereditary angioedema (HAE) is a rare hereditary disease characterized by edema, which can be life‐threatening in case of swelling in the larynx. The most common form of HAE is caused by a mutation of the SERPING1 gene and is characterized by a deficiency (type I) or loss of function (type II) of the C1 inhibitor (C1‐INH), leading to excessive ...
Andreas Recke
wiley   +1 more source

Alternative Renin-Angiotensin System. [PDF]

Hypertension
Bader M, Steckelings UM, Alenina N, Santos RAS, Ferrario CM.   +4 more
europepmc   +1 more source

Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate whether initiating sodium‐glucose cotransporter 2 inhibitors (SGLT2i) within 3 months after a urinary tract infection (UTI) is associated with improved long‐term outcomes in patients with type 2 diabetes mellitus (T2DM), compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i).
Hsiao‐Wei Wang, Ming‐Hsien Tsai, Yu‐Wei Fang, Kuo‐Cheng Lu, Joshua Wang, Chien‐Lin Lu   +5 more
wiley   +1 more source

Hyperkalemia and maintenance of renin-angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors. [PDF]

Nephrol Dial Transplant
Bosi A, Xu Y, Faucon AL, Huang T, Evans M, Shin JI, Fu EL, Carrero JJ.   +7 more
europepmc   +1 more source

Salt sensitivity in goldblatt hypertensive rats. Role of extracellular fluid volume and renin-angiotensin system.

, 1991
Yuji Sato, Katsuyuki Ando, Etsuro Ogata, Toshiro Fujita   +3 more
openalex   +2 more sources

Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.

American Journal of Kidney Diseases, 2016
Xinfang Xie, Youxia Liu, V. Perkovic, Xiangling Li, T. Ninomiya, W. Hou, Na Zhao, Lijun Liu, J. Lv, Hong Zhang, Hai-yan Wang   +10 more
semanticscholar   +1 more source

Gender differences in the prescription of SGLT2 inhibitors in chronic kidney disease: A real‐world database study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Chronic kidney disease (CKD) is a growing global health concern, and sodium‐glucose cotransporter 2 (SGLT2) inhibitors have emerged as a key treatment strategy. While their kidney‐protective effects are well established in both genders, women are prescribed these agents less frequently than men for the treatment of type 2 diabetes ...
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Kazuki Aoyama, Takashin Nakayama, Katsuhito Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +14 more
wiley   +1 more source

Do Exosomes Add Another Bi-Layer of Complexity to the Renin-Angiotensin System? [PDF]

Kidney360
Gonzalez-Villalobos RA.
europepmc   +1 more source